Aquestive announced on August 15, 2025, that its forecast growth exceeded the industry average for the pharmaceuticals sector.
2 reports, 2 independent
Updated Aug 15
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Aquestive announced on August 15, 2025, that its forecast growth exceeded the industry average for the pharmaceuticals sector.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Aquestive's forecast growth exceeded industry average in August 2025.1 source
Aquestive and Arbutus Biopharma outperformed the medical sector in August 2025.1 source
Keep exploring
The entities involved
-
Aquestive (United States)
company in Warren Township, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.Aquestive Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag Explore Aquestive Therapeutics's Fair Values from the Community and select yours Revenue: US$10.0m (down 50%
- ZacksIs Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year? Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Aq